BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 10960943)

  • 1. Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma.
    Hainsworth JD; Burris HA; Erland JB; Morrissey LH; Meluch AA; Kalman LA; Hon JK; Scullin DC; Smith SW; Greco FA
    Cancer; 1999 Mar; 85(6):1269-76. PubMed ID: 10189131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancer.
    Burris HA; Hainsworth JD; Erland JB; Morrissey LH; Kalman LA; Hon JK; Scullin DC; Smith SW; Greco FA
    Semin Oncol; 2000 Feb; 27(1 Suppl 2):9-13. PubMed ID: 10697030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.
    Hirsh V; Soulieres D; Duclos M; Faria S; Del Vecchio P; Ofiara L; Ayoub JP; Charpentier D; Gruber J; Portelance L; Souhami L
    J Thorac Oncol; 2007 Oct; 2(10):927-32. PubMed ID: 17909355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New triplet chemotherapy combination with carboplatin, paclitaxel and gemcitabine plus amifostine support in advanced non small cell lung cancer: a phase II study.
    Illiano A; Barletta E; De Marino V; Battiloro C; Barzelloni M; Scognamiglio F; Rossi N; Zampa G; De Bellis M; Gridelli C
    Anticancer Res; 2000; 20(5C):3999-4003. PubMed ID: 11268491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective analysis of outcomes across histological subgroups in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin for advanced non-small cell lung cancer.
    Treat J; Edelman MJ; Belani CP; Socinski MA; Monberg MJ; Chen R; Obasaju CK;
    Lung Cancer; 2010 Dec; 70(3):340-6. PubMed ID: 20347506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine, paclitaxel, and carboplatin for advanced non-small-cell lung cancer.
    Greco FA; Burris HA; Hainsworth JD
    Oncology (Williston Park); 2000 Jul; 14(7 Suppl 4):31-4. PubMed ID: 10960943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine/carboplatin in advanced non-small cell lung cancer.
    Zatloukal P; Petruzelka L
    Lung Cancer; 2002 Nov; 38 Suppl 2():S33-6. PubMed ID: 12431827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine and carboplatin in combination: an update of phase I and phase II studies in non-small cell lung cancer.
    Langer CJ; Gandara DR; Calvert P; Edelman MJ; Ozols RF
    Semin Oncol; 1999 Feb; 26(1 Suppl 4):12-8. PubMed ID: 10201516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine plus paclitaxel versus carboplatin plus either gemcitabine or paclitaxel in advanced non-small-cell lung cancer: a literature-based meta-analysis.
    Li C; Sun Y; Pan Y; Wang Q; Yang S; Chen H
    Lung; 2010 Oct; 188(5):359-64. PubMed ID: 20703493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine/carboplatin combination regimens: importance of dose schedule.
    Gandara DR; Lau DH; Lara PN; Edelman MJ
    Oncology (Williston Park); 2000 Jul; 14(7 Suppl 4):26-30. PubMed ID: 10960942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine for the treatment of non-small-cell lung cancer.
    Johnson DH
    Oncology (Williston Park); 2001 Mar; 15(3 Suppl 6):33-9. PubMed ID: 11301846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine and carboplatin in combination: phase I and phase II studies.
    Langer CJ; Calvert P; Ozols RF
    Semin Oncol; 1998 Aug; 25(4 Suppl 9):51-4. PubMed ID: 9728585
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.